We are enclosing herewith the Notice of the AGM to be held on Saturday, 27th September 2025 along with the Annual Report of the Financial Year 2024-2025 as required under Regulation 34 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TCM Limited (formerly Travancore Chemical & Mfg. Co. Ltd.), a BSE-listed company, has submitted its 81st AGM Notice and Annual Report for FY 2024-25. The AGM is scheduled for 27th September 2025 at Bharat Hotel, Ernakulam. For FY25, the company reported a standalone total income of Rs. 2950.82 lakhs and net profit of Rs. 326.37 lakhs, turning around from a consolidated loss of Rs. 228.92 lakhs in FY24. The board has not recommended any dividend, citing insufficient profits for distribution. A key special business item is seeking shareholder approval for a related-party joint development agreement with Asset Homes TCM Township Private Limited for 11 acres of land at Trikkakara, Ernakulam — involving Mr. Joseph Varghese (Managing Director) as a common director — under which TCM will receive Rs. 6 lakh per cent plus 45% of net project profit. Additionally, JKM Associates is proposed as Secretarial Auditor for a five-year term (FY26 to FY30).
For shareholders, the AGM approval of the Asset Homes joint development is critical as it could unlock long-pending value in the 11-acre Kerala land (now charge-free after the Rs. 15 crore Godrej Properties settlement in March 2025). However, the absence of a dividend despite a return to profitability may disappoint income-seeking investors, while the related-party nature of the deal warrants shareholder scrutiny.